Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TQB-2858 by Chia Tai Tianqing Pharmaceutical Group for Nasopharyngeal Cancer: Likelihood of Approval
TQB-2858 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase II for Nasopharyngeal Cancer. According...